News & views
Our collective understanding of mental health is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.
For media inquiries, contact us at email@example.com
Article discussing the granted psilocybin patent. Featuring a comment from co-founder George Goldsmith on what this means for COMPASS Pathways.
To make sure it is safe and effective in patients, psilocybin therapy needs to be approved by medical regulators, not legislators.
The cost of developing psilocybin therapy, with clinical trials in multiple countries, is significant, and involves considerable risk and resource. We think it’s an investment worth making.
Psilocybin therapy is unusual because it’s an innovative protocol that combines a medicine with psychological support.
Here we explain our full commitment to Open Science, including publishing the results from all our trials and supporting the publication of all results from independent studies that use our psilocybin.
Our therapist training programme has been designed by experts from the fields of psychology, psychiatry and psychedelic therapy research.
Here are highlights of our activities in the second half of 2019 that we hope will move us closer to our goal of improving mental health care for as many as possible.
Video courtesy of CNS Summit
An overview of the healthy volunteer study at Kings College London, where COMPASS Pathways COMP360 (psilocybin) was found to be well tolerated.
Here are highlights of our activities in the first half of 2019 that we hope will move us closer to our goal of improving mental health care for as many as possible.
As 2018 draws to a close, we reflect on another busy year and share our highlights of the last few months with you.
Article written for the MAPS Bulletin Winter 2018. By Ekaterina Malievskaia, MD, MSc
COMPASS Pathways, a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health ...
This is the second of regular newsletters from COMPASS, highlighting recent and forthcoming events and developments that are relevant to us, our partners and healthcare system stakeholders.
The holiday season is approaching, and as we begin dreaming of festive treats and spending the holidays cocooned in thick duvets with a cup of hot chocolate in hand, I would like to reflect on our journey this past year and share a few 2017 highlights.